https://solidus.ambrosiaventures.co/blog 2026-09-09T00:13:20.074Z daily 0.8 https://solidus.ambrosiaventures.co/blog/mrna-ophthalmology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:42.215Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/novartis-acquires-myricx-for-11b-adc-oncology-deal-decoded 2026-09-09T00:12:42.473Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-up-6100-in-2026-heres-the-data 2026-07-22T17:19:59.298Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-4500-in-2026-heres-the-data 2026-07-22T15:31:47.113Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/phase-2-monoclonal-antibody-neurology-acquisition-deal-terms-2025-analysis 2026-09-09T00:12:41.647Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gilead-sciences-deal-activity-20-deals-analyzed 2026-09-09T00:12:41.851Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gilead-deal-activity-10-deals-analyzed-20172026 2026-09-09T00:12:42.019Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-pitchbook-biopharma-deal-benchmarking-compared 2026-07-22T15:31:46.100Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data-zci1s 2026-08-22T06:11:06.494Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-9ocgo 2026-08-25T06:11:19.795Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-3000-in-2026-heres-the-data 2026-08-27T06:07:02.954Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-jttk8 2026-08-28T06:06:36.096Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/sanofi-deal-activity-35-deals-analyzed-20172026 2026-09-09T00:12:43.077Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-development-deals-are-up-1200-in-2026-heres-the-data 2026-08-28T06:11:41.946Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-4100-in-2026-heres-the-data 2026-07-22T15:31:46.290Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-1271-in-6-months-ze8ol 2026-08-22T06:12:27.465Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data-9q462 2026-08-25T06:12:42.538Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-4g2op 2026-08-27T06:08:14.327Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-jvj4m 2026-08-28T06:07:55.859Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/protac-gastroenterology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:43.582Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3300-in-2026-heres-the-data 2026-07-22T17:14:15.166Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-bets-700m-on-nurix-protein-degrader-deal-analysis 2026-09-09T00:12:44.789Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-ejqei 2026-08-23T06:04:24.141Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-1271-in-6-months-9rsbk 2026-08-25T06:14:00.310Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/pfizer3sbio-62b-ssgj-707-deal-structure-breakdown 2026-09-09T00:12:43.996Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/na-standalone-deal-activity-17-deals-analyzed 2026-09-09T00:12:44.171Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-hematology-licensing-deal-terms-phase-2-2024-25-data 2026-09-09T00:12:44.543Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/jj-deal-activity-16-deals-analyzed-20172026 2026-09-09T00:12:45.217Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/astrazeneca-cspc-pharmaceutical-185b-deal-structure-breakdown 2026-09-09T00:12:45.785Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/astrazeneca-deal-activity-42-deals-analyzed-20202026 2026-09-09T00:12:46.014Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/monoclonal-antibody-immunology-acquisition-deal-terms-at-phase-2 2026-09-09T00:12:46.311Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/car-t-hematologic-dermatology-acquisition-deal-terms-phase-2 2026-09-09T00:12:46.632Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-metabolic-cdmo-deals-average-1847m-upfront 2026-09-09T00:12:46.871Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/abbvie-deal-activity-59-deals-analyzed-20232026 2026-09-09T00:12:45.501Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3900-in-h1 2026-07-25T06:13:07.063Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-4000-in-6-months 2026-07-22T17:14:34.446Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3400-in-6-months-elhis 2026-08-23T06:05:46.155Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-4hqw2 2026-08-27T06:09:32.334Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/astrazeneca-cspc-47b-option-deal-structure-breakdown 2026-09-09T00:12:47.615Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/eli-lilly-deal-activity-2026-14-deals-analyzed 2026-09-09T00:12:47.217Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/pfizer-3sbio-63b-option-deal-structure-breakdown 2026-09-09T00:12:47.390Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rnai-rare-disease-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:47.997Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bayer-licensing-strategy-13-deals-analyzed 2026-09-09T00:12:48.317Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data 2026-08-23T06:06:59.298Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-dealforma-deal-benchmarking-compared 2026-07-22T15:31:46.598Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-neurology-acquisition-deal-terms-at-phase-2 2026-09-09T00:12:48.757Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-eot6v 2026-08-23T06:08:21.203Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-up-6100-in-2026-whats-driving-it 2026-08-12T06:11:59.365Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bmshengrui-152b-collaboration-deal-structure-breakdown 2026-09-09T00:12:48.934Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data 2026-07-22T17:14:33.422Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/novartismyricx-bio-15b-adc-deal-structure-breakdown 2026-09-09T00:12:49.117Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/novo-nordisk-omeros-24b-deal-structure-breakdown 2026-09-09T00:12:49.601Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-eqpjd 2026-08-23T06:09:49.812Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/astrazenecadizal-15b-zegfrovy-license-deal-breakdown 2026-09-09T00:12:49.744Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data 2026-07-22T17:19:59.640Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mrna-gastroenterology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:49.903Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-deals-up-1800-in-2026-data 2026-08-23T06:11:08.580Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/eli-lilly-limmatech-23b-vaccine-deal-structure-breakdown 2026-09-09T00:12:50.140Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-activity-up-6100-in-2026-heres-the-data-owkon 2026-08-26T06:05:24.101Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-4700-in-6-months 2026-07-22T15:31:46.959Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-activity-is-up-6100-in-2026-heres-the-data 2026-07-29T06:02:39.117Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-eu47c 2026-08-23T06:12:28.592Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-3400-in-2026-heres-the-data-oy3w1 2026-08-26T06:06:35.651Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data 2026-08-27T06:10:49.220Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data-evnms 2026-08-23T06:13:40.428Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/oligonucleotide-deals-up-2400-in-2026-heres-the-data 2026-07-22T15:31:46.658Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-small-molecule-womens-health-deal-terms-2026-benchmarks 2026-09-09T00:12:50.640Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-1271-in-6-months 2026-08-23T06:15:03.034Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3400-in-2026-heres-the-data-ozt61 2026-08-26T06:07:55.080Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-4700-in-2026-heres-the-data 2026-07-22T15:31:46.825Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/novartis-deal-activity-56-deals-analyzed-20242026 2026-09-09T00:12:51.069Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-rare-disease-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:50.780Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-immunology-deals-190m-median-upfront-in-2026 2026-09-09T00:12:50.946Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-activity-up-6100-in-2026-heres-the-data 2026-07-26T06:08:23.809Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-mrna-infectious-disease-deals-75m-median-upfront 2026-09-09T00:12:51.353Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-tznkc 2026-08-24T06:04:27.337Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-jlqhe 2026-08-21T06:02:37.245Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-3400-in-2026-heres-the-data 2026-08-24T06:05:45.229Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/protac-dermatology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:52.740Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-the-data-p1f4a 2026-08-26T06:09:10.338Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-1271-in-2026-heres-the-data 2026-08-27T06:12:02.835Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-4900-in-6-months 2026-07-22T18:25:36.582Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rnai-dermatology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:52.905Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/janssen-licensing-deals-2026-9-deals-analyzed 2026-09-09T00:12:53.093Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3400-in-6-months 2026-08-21T06:03:49.813Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3400-in-2026-heres-the-data-u3344 2026-08-24T06:07:07.478Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-infectious-disease-deals-average-139m-upfront 2026-09-09T00:12:53.348Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-globaldata-deal-benchmarking-compared 2026-07-22T15:31:47.163Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-trends-2026-activity-up-6100-in-six-months 2026-07-23T06:07:31.136Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-p30pv 2026-08-26T06:10:24.976Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/peptide-womens-health-licensing-deal-terms-at-phase-2-2025-guide 2026-09-09T00:12:53.477Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-deals-up-2000-in-2026-the-data 2026-07-22T17:14:38.295Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gi-deals-are-up-1100-in-2026-heres-the-data 2026-08-28T06:13:06.646Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/car-t-hematologic-gastroenterology-licensing-deal-terms-phase-2 2026-09-09T00:12:53.857Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3400-in-2026-heres-the-data 2026-08-21T06:05:00.500Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-evaluate-pharma-deal-benchmarking-compared 2026-07-22T15:31:47.069Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-u4rz9 2026-08-24T06:08:26.351Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data 2026-07-22T17:14:38.655Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-dermatology-deals-average-612m-upfront-in-2026 2026-09-09T00:12:54.013Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3900-in-6-months 2026-07-23T06:08:47.711Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-cortellis-deal-benchmarking-compared 2026-07-22T15:31:47.316Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-jqc6q 2026-08-21T06:06:12.007Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-u6hvj 2026-08-24T06:09:46.572Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-metabolic-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:54.280Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-p4oif 2026-08-26T06:11:42.311Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-ophthalmology-deals-average-1750m-upfront-in-2026 2026-09-09T00:12:54.539Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-1860-in-2026-heres-the-data 2026-07-22T17:14:05.151Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-jmv3l 2026-08-28T06:01:11.646Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/peptide-deals-are-up-1200-in-2026-heres-the-data 2026-07-22T17:13:51.419Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/protac-womens-health-licensing-deal-terms-at-phase-2-full-breakdown 2026-09-09T00:12:54.812Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-js3m2 2026-08-21T06:07:34.051Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-deals-up-1800-in-2026-the-data-u8anw 2026-08-24T06:11:10.548Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/monoclonal-antibody-metabolic-acquisition-deal-terms-at-phase-2 2026-09-09T00:12:54.933Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/oligonucleotide-deals-are-up-2400-in-2026-heres-the-data 2026-07-22T15:31:47.582Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-4300-in-2026-heres-the-data 2026-07-22T15:31:47.355Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data 2026-07-22T17:14:04.509Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-activity-up-6100-in-2026-the-data 2026-07-24T06:05:42.243Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-deal-activity-53-deals-analyzed-20232026 2026-09-09T00:12:55.147Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/protac-ophthalmology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:55.370Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-3900-in-2026-heres-the-data 2026-07-29T06:11:39.006Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-hematology-deals-average-2000m-upfront-in-2026 2026-09-09T00:12:55.250Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/antibody-deals-are-up-2800-in-2026-heres-the-data 2026-07-22T15:31:47.681Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-gene-therapy-rare-disease-deals-185m-median-upfront 2026-09-09T00:12:55.759Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-trends-2026-activity-surges-6100-in-6-months 2026-07-27T06:05:53.276Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/glp-1-agonist-oncology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:56.015Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-metabolic-small-molecule-deals-115m-median-upfront-in-2026 2026-09-09T00:12:56.151Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gsk-deal-activity-39-deals-analyzed-20212026 2026-09-09T00:12:56.334Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-deals-up-1800-in-2026-the-data 2026-08-21T06:08:53.311Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/protac-infectious-disease-acquisition-deal-terms-at-phase-2 2026-09-09T00:12:55.881Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-jvk8k 2026-08-21T06:10:15.573Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-up-3900-in-6-months 2026-07-27T06:08:32.281Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/boehringer-ingelheim-deal-activity-15-deals-analyzed 2026-09-09T00:12:56.794Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/phase-2-monoclonal-antibody-rare-disease-licensing-deal-terms-2025-benchmarks 2026-09-09T00:12:56.572Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-3900-in-6-months 2026-07-24T06:08:20.612Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gsk-acquires-nuvalent-for-106b-oncology-deal-analysis 2026-09-09T00:12:56.682Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3300-in-2026-heres-the-data 2026-07-24T06:09:23.269Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-infectious-disease-licensing-deal-terms-at-phase-2 2026-09-09T00:12:57.112Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-hematology-licensing-deal-terms-at-phase-2-2024-2025-benchmarks 2026-09-09T00:12:57.369Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mrna-dermatology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:57.639Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data 2026-08-21T06:11:34.704Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-neurology-deals-average-1375m-upfront-in-2026 2026-09-09T00:12:57.242Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-metabolic-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:57.897Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/astrazeneca-sino-biopharmaceutical-19b-tqc3721-deal-breakdown 2026-09-09T00:12:58.038Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/jazzabcellera-40b-t-cell-engager-deal-structure-breakdown 2026-09-09T00:12:58.149Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/phase-2-monoclonal-antibody-cardiovascular-licensing-deal-terms-2025-benchmarks 2026-09-09T00:12:58.346Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/car-t-hematologic-womens-health-licensing-deal-terms-phase-2 2026-09-09T00:12:58.481Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/oncology-deals-are-up-1480-in-2026-heres-the-data 2026-08-21T06:12:53.610Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-ua1s6 2026-08-24T06:12:32.337Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-1271-in-6-months 2026-08-21T06:14:04.649Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-immunology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:59.103Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-the-data 2026-07-24T06:11:56.590Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-up-1600-in-2026-heres-the-data 2026-07-22T17:19:28.948Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data-ubkcs 2026-08-24T06:13:43.069Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-rare-disease-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:59.418Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rnai-hematology-acquisition-deal-terms-at-phase-2-2024-2025-benchmarks 2026-09-09T00:12:59.604Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-activity-up-6100-in-2026-heres-the-data-z0ccz 2026-08-22T06:01:39.200Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-1271-in-6-months-udb71 2026-08-24T06:15:04.511Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mrna-infectious-disease-acquisition-deal-terms-at-phase-2-20242025-benchmarks 2026-09-09T00:13:00.306Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-metabolic-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:59.935Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-neurology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:13:00.140Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/takeda-deal-activity-16-deals-analyzed-20192026 2026-09-09T00:13:00.777Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/anti-vegf-oncology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:13:01.065Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/car-t-ophthalmology-acquisition-deal-terms-phase-2-2025-benchmarks 2026-09-09T00:13:01.413Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-up-6100-in-2026-whats-driving-the-surge 2026-08-05T06:02:32.866Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ambrosia-vs-biopharma-dive-deal-benchmarking-compared 2026-07-22T15:31:47.034Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-trends-2026-activity-up-6100-in-6-months 2026-07-30T06:08:07.124Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/biogen-deal-activity-21-deals-analyzed-20182026 2026-09-09T00:13:16.351Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3600-in-6-months 2026-08-05T06:03:42.109Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1600-in-2026-heres-the-data-p6eiu 2026-08-26T06:13:02.697Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/eli-lilly-deal-activity-38-deals-analyzed-20252026 2026-09-09T00:13:16.076Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/pfizer-deal-activity-41-deals-analyzed-20202026 2026-09-09T00:13:16.188Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deal-trends-2026-activity-surges-6100-in-six-months 2026-07-25T06:05:19.500Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3400-in-6-months-z2160 2026-08-22T06:02:58.042Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-5000-in-2026-heres-the-data 2026-07-22T15:31:47.018Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-hanmi-pharm-23b-license-deal-structure-breakdown 2026-09-09T00:13:16.570Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rnai-ophthalmology-licensing-deal-terms-at-phase-2-full-breakdown 2026-09-09T00:13:16.726Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rayzebiobmsphilochem-14b-radiopharm-deal-breakdown 2026-09-09T00:13:16.859Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/peptide-gastroenterology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:13:16.989Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3400-in-2026-heres-the-data-z3tzt 2026-08-22T06:04:21.855Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-9g8ut 2026-08-25T06:05:02.085Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-hanmi-obesity-deal-190m-bet-on-lean-mass 2026-09-09T00:13:17.238Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-peptide-dermatology-deal-terms-525m-median-upfront 2026-09-09T00:13:17.500Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-cardiovascular-acquisition-deal-terms-at-phase-2 2026-09-09T00:13:17.771Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/radiopharmaceutical-womens-health-acquisition-deal-terms-at-phase-2 2026-09-09T00:13:17.367Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-immunology-licensing-deal-terms-phase-2-2025-benchmarks 2026-09-09T00:13:17.634Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-oncology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:13:18.126Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/radiopharmaceutical-gastroenterology-acquisition-deal-terms-at-phase-2 2026-09-09T00:13:18.257Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rnai-infectious-disease-licensing-deal-terms-at-phase-2-2024-2025-benchmarks 2026-09-09T00:13:18.380Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/antibody-deals-are-up-2900-in-2026-heres-the-data 2026-07-22T15:31:48.312Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-z5j89 2026-08-22T06:05:41.400Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-3400-in-6-months-9hyl9 2026-08-25T06:06:21.864Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data-joket 2026-08-28T06:02:30.929Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-z7cen 2026-08-22T06:07:05.700Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data-9jpde 2026-08-25T06:07:43.431Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-up-6100-in-2026-whats-driving-the-surge-49jux 2026-08-27T06:03:09.981Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/jj-bets-26b-on-sail-bios-in-vivo-car-t-platform 2026-09-09T00:13:18.740Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/abcellera-vertex-partner-on-t-cell-engagers-deal-intel 2026-09-09T00:13:18.848Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bispecific-antibody-deals-up-1800-in-2026-the-data-z93sg 2026-08-22T06:08:27.836Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-9l843 2026-08-25T06:08:54.191Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data-4b9v2 2026-08-27T06:04:30.343Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-jqbqt 2026-08-28T06:03:53.038Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-jx859 2026-08-28T06:09:14.951Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-z33bs 2026-08-29T06:01:29.061Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-z65vr 2026-08-29T06:03:52.534Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-z9hi6 2026-08-29T06:06:27.390Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-zcpc2 2026-08-29T06:08:57.810Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data 2026-08-29T06:11:30.935Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-zatlt 2026-08-22T06:09:47.954Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-deals-are-up-1900-in-2026-heres-the-data-9mske 2026-08-25T06:10:07.340Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-4cvmu 2026-08-27T06:05:45.242Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-2700-in-2026-heres-the-data 2026-08-28T06:05:09.760Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-1271-in-2026-heres-the-data-jypus 2026-08-28T06:10:24.559Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data-z4ny1 2026-08-29T06:02:42.595Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-2600-in-6-months 2026-08-29T06:05:10.665Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-zb3qd 2026-08-29T06:07:42.836Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-1271-in-6-months-ze5k1 2026-08-29T06:10:05.185Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gastroenterology-deals-up-1100-in-2026-heres-the-data 2026-08-29T06:12:40.922Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-eiu8n 2026-08-30T06:01:24.201Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-3400-in-2026-heres-the-data-ekmhn 2026-08-30T06:02:47.667Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-heres-the-data-em3da 2026-08-30T06:03:56.170Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-2400-in-6-months 2026-08-30T06:05:15.692Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-ephfs 2026-08-30T06:06:34.430Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-up-1700-in-2026-heres-the-data 2026-08-30T06:07:49.964Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deals-are-up-1500-in-2026-heres-the-data 2026-08-30T06:08:55.860Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-eu3vx 2026-08-30T06:10:09.917Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gastroenterology-deals-up-1100-in-2026-the-data 2026-08-30T06:11:27.617Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-are-up-1033-in-2026-heres-the-data 2026-08-30T06:12:47.239Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-tyq0c 2026-08-31T06:01:25.623Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-3400-in-2026-heres-the-data-u0fjn 2026-08-31T06:02:45.373Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-deals-up-3067-in-2026-the-data-u1vet 2026-08-31T06:03:52.830Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-surges-2400-in-6-months 2026-08-31T06:05:11.577Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-u5f3f 2026-08-31T06:06:38.075Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-up-1700-in-2026-heres-the-data-u79zj 2026-08-31T06:08:04.940Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-are-up-1600-in-2026-heres-the-data 2026-08-31T06:09:19.015Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/other-deal-trends-2026-activity-up-1500-in-6-months 2026-08-31T06:10:29.767Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-uc4ee 2026-08-31T06:11:50.801Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gastroenterology-deals-are-up-1100-in-2026-heres-the-data 2026-08-31T06:13:04.540Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-9gbzu 2026-09-01T06:02:47.691Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-2000-in-2026-heres-the-data 2026-09-01T06:06:35.845Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-9okh7 2026-09-01T06:09:11.944Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-9rzp3 2026-09-01T06:11:51.629Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-9tsm1 2026-09-01T06:13:15.908Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-owbbi 2026-09-02T06:02:53.889Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/jjfirefly-bio-1b-adc-acquisition-deal-structure-breakdown 2026-09-09T00:13:19.228Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/genentech-hanmi-pharmaceutical-23b-deal-structure-breakdown 2026-09-09T00:13:19.350Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/jjsail-biomedicines-35b-option-deal-structure-breakdown 2026-09-09T00:13:19.471Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/eli-lilly-merida-biosciences-29b-deal-structure-breakdown 2026-09-09T00:13:19.604Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-2000-in-2026-heres-the-data 2026-09-02T06:04:23.648Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-p1gd2 2026-09-02T06:06:53.536Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-up-1700-in-2026-heres-the-data 2026-09-02T06:08:19.271Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-p6ldk 2026-09-02T06:10:53.351Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-p834l 2026-09-02T06:12:02.983Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rochehanmi-pharmaceutical-23b-deal-structure-breakdown 2026-09-09T00:13:19.730Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rochegenentechhanmi-23b-license-deal-structure-breakdown 2026-09-09T00:13:19.834Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-4a3cl 2026-09-03T06:01:17.146Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-2000-in-2026-heres-the-data-4btbe 2026-09-03T06:02:37.289Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-4dmok 2026-09-03T06:04:02.008Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-are-up-1700-in-2026-heres-the-data 2026-09-03T06:05:26.936Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-4h4xa 2026-09-03T06:06:45.620Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-4iq6d 2026-09-03T06:08:00.043Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ophthalmology-deals-up-1100-in-2026-heres-the-data 2026-09-03T06:09:14.300Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gastroenterology-deals-up-1100-in-2026-the-data-4lv7y 2026-09-03T06:10:26.494Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-deals-are-up-800-in-2026-heres-the-data 2026-09-03T06:11:36.636Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/peptide-deals-are-up-750-in-2026-heres-the-data 2026-09-03T06:12:47.358Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-jrq6r 2026-09-04T06:02:40.162Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-2000-in-2026-heres-the-data-jtpsa 2026-09-04T06:04:13.147Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-jvlm5 2026-09-04T06:05:40.876Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-are-up-1700-in-2026-heres-the-data-jx4l9 2026-09-04T06:06:52.119Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-jykv3 2026-09-04T06:08:00.071Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-k0crb 2026-09-04T06:09:22.850Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ophthalmology-deals-up-1100-in-2026-heres-the-data-k1u91 2026-09-04T06:10:31.992Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gastroenterology-deals-up-1100-in-2026-heres-the-data-k3gxv 2026-09-04T06:11:48.075Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/cell-therapy-deals-are-up-800-in-2026-heres-the-data-k52jd 2026-09-04T06:13:02.711Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-z7zi6 2026-09-05T06:02:59.293Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-up-2000-in-2026-heres-the-data-z9su5 2026-09-05T06:04:23.822Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-zbjio 2026-09-05T06:05:45.122Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-up-1700-in-2026-heres-the-data-zd6yu 2026-09-05T06:07:02.275Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-zg65k 2026-09-05T06:09:21.040Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-zhqsm 2026-09-05T06:10:34.622Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ophthalmology-deals-are-up-1100-in-2026-heres-the-data 2026-09-05T06:11:58.553Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mega-deals-are-up-6100-in-2026-heres-the-data-eo1h3 2026-09-06T06:03:08.620Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/rare-disease-deals-are-up-2000-in-2026-heres-the-data-epqcj 2026-09-06T06:04:27.666Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/vaccine-deals-are-up-1700-in-2026-heres-the-data-erbvp 2026-09-06T06:05:42.261Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/hematology-deals-are-up-1700-in-2026-heres-the-data-esyq6 2026-09-06T06:06:58.541Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/co-dev-deals-are-up-1200-in-2026-heres-the-data-eujqw 2026-09-06T06:08:12.252Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/ophthalmology-deals-are-up-1100-in-2026-heres-the-data-ew3wu 2026-09-06T06:09:25.034Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gi-deals-are-up-1100-in-2026-heres-the-data-exqsd 2026-09-06T06:10:41.338Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-deals-up-1067-in-2026-heres-the-data 2026-09-06T06:11:54.358Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-pathai-15b-acquisition-deal-structure-breakdown 2026-09-09T00:12:41.370Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/aso-womens-health-acquisition-deal-terms-at-phase-2-benchmarks 2026-09-09T00:12:42.906Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-small-molecule-oncology-deals-average-24b-upfront 2026-09-09T00:12:43.274Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-immunology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:43.815Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-gene-therapy-ophthalmology-deals-40m-upfront 2026-09-09T00:12:44.982Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-bets-700m-on-nurixs-btk-degrader-deal-decoded 2026-09-09T00:12:47.039Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-bispecific-antibody-deals-average-55m-upfront-in-2026 2026-09-09T00:12:48.151Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/roche-nurix-700m-protein-degrader-deal-structure-breakdown 2026-09-09T00:12:48.580Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/lilly-ascidian-19b-rna-exon-editing-deal-what-bd-teams-need-to-know 2026-09-09T00:12:49.336Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bms-deal-activity-13-deals-analyzed-20192026 2026-09-09T00:12:50.028Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/eli-lilly-ajax-therapeutics-23b-deal-structure-breakdown 2026-09-09T00:12:50.518Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/bristol-myers-squibb-deal-activity-15-deals-analyzed 2026-09-09T00:12:51.200Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/novo-nordisk-deal-activity-21-deals-analyzed-20182026 2026-09-09T00:12:52.592Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/anti-vegf-neurology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:53.234Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-immunology-antibody-deals-87b-median-upfront-in-2026 2026-09-09T00:12:53.585Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/merck-deal-activity-40-deals-analyzed-20192026 2026-09-09T00:12:54.139Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-gene-therapy-cv-deals-98m-median-upfront-in-2026 2026-09-09T00:12:56.448Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-cv-small-molecule-deals-350m-median-upfront 2026-09-09T00:12:59.786Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-oligonucleotide-gi-deals-average-35m-upfront 2026-09-09T00:12:54.665Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/royalty-pharma-revolution-medicines-20b-deal-breakdown 2026-09-09T00:12:55.041Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/preclinical-gene-therapy-neurology-deals-average-73m-upfront 2026-09-09T00:12:55.473Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/adc-neurology-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:57.773Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/mrna-hematology-acquisition-deal-terms-phase-2-2024-2025-benchmarks 2026-09-09T00:13:17.117Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-cardiovascular-licensing-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:12:56.947Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/genentech-deal-activity-13-deals-analyzed-20202026 2026-09-09T00:13:18.969Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gene-therapy-cardiovascular-acquisition-deal-terms-at-phase-2 2026-09-09T00:12:58.845Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/peptide-dermatology-acquisition-deal-terms-at-phase-2-2025-analysis 2026-09-09T00:13:00.619Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/approved-rare-disease-deals-average-3050m-upfront-in-2026 2026-09-09T00:13:16.455Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/small-molecule-oncology-acquisition-deal-terms-at-phase-2-2025-benchmarks 2026-09-09T00:13:17.995Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/regeneron-deal-activity-13-deals-analyzed-20192026 2026-09-09T00:13:19.108Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gsk-hutchmed-13b-license-deal-structure-breakdown 2026-09-09T00:13:19.960Z monthly 0.7 https://solidus.ambrosiaventures.co/blog/gsk-bets-13b-on-hutchmeds-egfrkras-asset-deal-decoded 2026-09-09T00:13:20.074Z monthly 0.7 https://solidus.ambrosiaventures.co/therapeutic-vaccine-licensing-calculator 2026-02-02T05:11:32.236Z monthly 0.8 https://solidus.ambrosiaventures.co/peptide-drug-licensing-deal-calculator 2026-02-02T05:11:32.793Z monthly 0.8 https://solidus.ambrosiaventures.co/car-t-hematologic-cancer-licensing-calculator 2026-02-02T05:11:33.334Z monthly 0.8 https://solidus.ambrosiaventures.co/t-cell-engager-licensing-deal-calculator 2026-02-02T05:11:33.848Z monthly 0.8 https://solidus.ambrosiaventures.co/monoclonal-antibody-licensing-calculator 2026-02-02T05:11:34.362Z monthly 0.8 https://solidus.ambrosiaventures.co/cell-therapy-licensing-deal-calculator 2026-02-02T05:12:03.273Z monthly 0.8 https://solidus.ambrosiaventures.co/small-molecule-licensing-deal-calculator 2026-02-02T05:12:03.725Z monthly 0.8 https://solidus.ambrosiaventures.co/protac-degrader-licensing-deal-calculator 2026-02-02T05:12:04.204Z monthly 0.8 https://solidus.ambrosiaventures.co/mrna-oncology-vaccine-licensing-calculator 2026-02-02T05:12:04.710Z monthly 0.8 https://solidus.ambrosiaventures.co/gene-therapy-licensing-deal-calculator 2026-02-02T05:12:05.134Z monthly 0.8 https://solidus.ambrosiaventures.co/car-t-cell-therapy-licensing-calculator 2026-02-02T05:12:05.531Z monthly 0.8 https://solidus.ambrosiaventures.co/radiopharmaceutical-licensing-deal-calculator 2026-02-02T05:12:06.503Z monthly 0.8 https://solidus.ambrosiaventures.co/molecular-glue-degrader-licensing-calculator 2026-02-02T05:11:31.287Z monthly 0.8 https://solidus.ambrosiaventures.co/rnai-sirna-licensing-deal-calculator 2026-02-02T05:11:30.818Z monthly 0.8 https://solidus.ambrosiaventures.co/oncolytic-virus-licensing-deal-calculator 2026-02-02T05:11:31.782Z monthly 0.8 https://solidus.ambrosiaventures.co/bispecific-antibody-deal-terms-calculator 2026-02-02T05:12:05.960Z monthly 0.8 https://solidus.ambrosiaventures.co/car-t-solid-tumor-cancer-licensing-deal-calculator 2026-02-02T05:15:42.322Z monthly 0.8 https://solidus.ambrosiaventures.co/adc-antibody-drug-conjugate-licensing-deal-calculator 2026-02-02T05:15:44.173Z monthly 0.8 https://solidus.ambrosiaventures.co/playbook/sanofi monthly 0.7 https://solidus.ambrosiaventures.co/playbook/eli-lilly monthly 0.7 https://solidus.ambrosiaventures.co/playbook/abbvie monthly 0.7 https://solidus.ambrosiaventures.co/playbook/astrazeneca monthly 0.7 https://solidus.ambrosiaventures.co/playbook/abbvie monthly 0.7 https://solidus.ambrosiaventures.co/playbook/novartis monthly 0.7 https://solidus.ambrosiaventures.co/playbook/merck monthly 0.7 https://solidus.ambrosiaventures.co/playbook/roche monthly 0.7 https://solidus.ambrosiaventures.co/playbook/novartis monthly 0.7 https://solidus.ambrosiaventures.co/playbook/roche monthly 0.7 https://solidus.ambrosiaventures.co/playbook/gilead-sciences monthly 0.7 https://solidus.ambrosiaventures.co/playbook/merck monthly 0.7 https://solidus.ambrosiaventures.co/playbook/bristol-myers-squibb monthly 0.7 https://solidus.ambrosiaventures.co/playbook/biogen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/astrazeneca monthly 0.7 https://solidus.ambrosiaventures.co/playbook/gilead-sciences monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sanofi monthly 0.7 https://solidus.ambrosiaventures.co/playbook/johnson-johnson monthly 0.7 https://solidus.ambrosiaventures.co/playbook/eli-lilly monthly 0.7 https://solidus.ambrosiaventures.co/playbook/regeneron monthly 0.7 https://solidus.ambrosiaventures.co/playbook/pfizer monthly 0.7 https://solidus.ambrosiaventures.co/playbook/johnson-johnson monthly 0.7 https://solidus.ambrosiaventures.co/playbook/biogen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/amgen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/bristol-myers-squibb monthly 0.7 https://solidus.ambrosiaventures.co/playbook/novo-nordisk monthly 0.7 https://solidus.ambrosiaventures.co/playbook/bayer monthly 0.7 https://solidus.ambrosiaventures.co/playbook/takeda monthly 0.7 https://solidus.ambrosiaventures.co/playbook/gsk monthly 0.7 https://solidus.ambrosiaventures.co/playbook/pfizer monthly 0.7 https://solidus.ambrosiaventures.co/playbook/novo-nordisk monthly 0.7 https://solidus.ambrosiaventures.co/playbook/moderna monthly 0.7 https://solidus.ambrosiaventures.co/playbook/pfizer-oncology monthly 0.7 https://solidus.ambrosiaventures.co/playbook/vertex monthly 0.7 https://solidus.ambrosiaventures.co/playbook/gsk monthly 0.7 https://solidus.ambrosiaventures.co/playbook/regeneron monthly 0.7 https://solidus.ambrosiaventures.co/playbook/boehringer-ingelheim monthly 0.7 https://solidus.ambrosiaventures.co/playbook/takeda monthly 0.7 https://solidus.ambrosiaventures.co/playbook/bayer monthly 0.7 https://solidus.ambrosiaventures.co/playbook/pfizer monthly 0.7 https://solidus.ambrosiaventures.co/playbook/boehringer-ingelheim monthly 0.7 https://solidus.ambrosiaventures.co/playbook/amgen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/astellas monthly 0.7 https://solidus.ambrosiaventures.co/playbook/alnylam-pharmaceuticals monthly 0.7 https://solidus.ambrosiaventures.co/playbook/organon monthly 0.7 https://solidus.ambrosiaventures.co/playbook/moderna monthly 0.7 https://solidus.ambrosiaventures.co/playbook/astellas-pharma monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sun-pharma monthly 0.7 https://solidus.ambrosiaventures.co/playbook/janssen-j-j monthly 0.7 https://solidus.ambrosiaventures.co/playbook/seagen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/viatris monthly 0.7 https://solidus.ambrosiaventures.co/playbook/abbvie monthly 0.7 https://solidus.ambrosiaventures.co/playbook/incyte monthly 0.7 https://solidus.ambrosiaventures.co/playbook/janssen-j-j monthly 0.7 https://solidus.ambrosiaventures.co/playbook/neurocrine-biosciences monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sarepta-therapeutics monthly 0.7 https://solidus.ambrosiaventures.co/playbook/vertex monthly 0.7 https://solidus.ambrosiaventures.co/playbook/jazz-pharmaceuticals monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sun-pharma-dermatology monthly 0.7 https://solidus.ambrosiaventures.co/playbook/viatris monthly 0.7 https://solidus.ambrosiaventures.co/playbook/chiesi-group monthly 0.7 https://solidus.ambrosiaventures.co/playbook/alexion monthly 0.7 https://solidus.ambrosiaventures.co/playbook/alexion-pharmaceuticals monthly 0.7 https://solidus.ambrosiaventures.co/playbook/moderna-tx-inc monthly 0.7 https://solidus.ambrosiaventures.co/playbook/abbvie-immunology monthly 0.7 https://solidus.ambrosiaventures.co/playbook/alfasigma monthly 0.7 https://solidus.ambrosiaventures.co/playbook/neurocrine-biosciences monthly 0.7 https://solidus.ambrosiaventures.co/playbook/roche-ophthalmology monthly 0.7 https://solidus.ambrosiaventures.co/playbook/smithkline-beecham-corporation-and-glaxo-group-limited-gsk monthly 0.7 https://solidus.ambrosiaventures.co/playbook/biontech monthly 0.7 https://solidus.ambrosiaventures.co/playbook/zai-lab monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sanofi-regeneron monthly 0.7 https://solidus.ambrosiaventures.co/playbook/roche-genentech monthly 0.7 https://solidus.ambrosiaventures.co/playbook/micron-biomedical monthly 0.7 https://solidus.ambrosiaventures.co/playbook/f-hoffmann-la-roche-ltd-and-hoffmann-la-roche-inc monthly 0.7 https://solidus.ambrosiaventures.co/playbook/sun-pharma monthly 0.7 https://solidus.ambrosiaventures.co/playbook/gsk-vaccines monthly 0.7 https://solidus.ambrosiaventures.co/playbook/madrigal-pharmaceuticals-inc monthly 0.7 https://solidus.ambrosiaventures.co/playbook/alnylam-pharmaceuticals monthly 0.7 https://solidus.ambrosiaventures.co/playbook/seagen monthly 0.7 https://solidus.ambrosiaventures.co/playbook/biomarin monthly 0.7 https://solidus.ambrosiaventures.co/playbook/organon monthly 0.7 https://solidus.ambrosiaventures.co/playbook/incyte monthly 0.7 https://solidus.ambrosiaventures.co/guides monthly 0.7 https://solidus.ambrosiaventures.co/guides/how-to-value-biotech-deal monthly 0.8 https://solidus.ambrosiaventures.co/guides/negotiate-pharma-royalty-rates monthly 0.8 https://solidus.ambrosiaventures.co/guides/biotech-licensing-deal-structure monthly 0.8 https://solidus.ambrosiaventures.co/guides/rnpv-biotech-valuation monthly 0.8 https://solidus.ambrosiaventures.co/guides/pharma-ma-vs-licensing monthly 0.8 https://solidus.ambrosiaventures.co/guides/biopharma-licensing-benchmarks monthly 0.9 https://solidus.ambrosiaventures.co/guides/life-sciences-deal-calculator-guide monthly 0.9 https://solidus.ambrosiaventures.co/guides/monte-carlo-biotech-valuation monthly 0.8 https://solidus.ambrosiaventures.co/reports monthly 0.7 https://solidus.ambrosiaventures.co/reports/deal-trends-2026 monthly 0.8 https://solidus.ambrosiaventures.co/reports/q1-2026-biopharma-deal-benchmarks monthly 0.9 https://solidus.ambrosiaventures.co/reports/q2-2026-biopharma-deal-benchmarks monthly 0.9 https://solidus.ambrosiaventures.co/press/data-kit monthly 0.8